Godavari Drugs Share Price

Godavari Drugs

CMP as on20-May-22 15:50

₹ 68.95
0.4 0.58%

Open

₹ 70.00

Turnover (lac)

₹ 9

Prev. Close

₹ 68.55

Day's Vol (shares)

₹ 4,707

Day's Range

₹ 67.50
₹ 70.30

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 13-Apr-2022 - -
GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/04/2022 inter alia to consider and approve 1. Audited Standalone Financial Results of the Company for the Fourth Quarter and Financial Year ended 31st March 2022. 2. To discuss and approve Draft Boards Report and Draft Management Discussion and Analysis Report for the Financial Year ended 31st March 2022 3. To Approve the notice calling 34th Annual General Meeting. Outcome of the Board Meeting held on 19.04.2022 commenced at 11:30 A.M. and concluded at 1:10 P.M. Approval of Financial Results for quarter and year ended 31.03.2022 (As Per BSE Announcement dated on 19.04.2022) Approval of Financial Results for quarter and year ended 31.03.2022 (As Per BSE Announcement Dated on 10.05.2022)
Board Meeting - 07-Feb-2022 - -
GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Unaudited Financial Statements for quarter ended December 2021 Outcome of the Board Meeting held on 14.02.2022 for approval of Unaudited Financial Statements for the quarter ended 31.12.2021. (As Per BSE Announcement Dated 14.02.2022)
Board Meeting - 03-Nov-2021 - -
Quarterly Results Outcome of the Board Meeting held on 12.11.2021 for approval of unaudited financials for the quarter ended 30.09.2021 (As per BSE Announcement Dated on 12/11/2021)
Board Meeting - 06-Aug-2021 - -
GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 inter alia to consider and approve Unaudited Financial Statements for the quarter ended 30.06.2021. Outcome of Board Meeting held on 14.08.2021 for approval of Unaudited Financial Statement Unaudited Financial Results for the quarter ended 30.06.2021 (As Per BSE Announcement Dated 14.08.2021)
Board Meeting - 10-Jun-2021 - -
GODAVARI DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/06/2021 ,inter alia, to consider and approve The Audited Financials for the Quarter and Financial Year ended 31.03.2021 Outcome of the Board Meeting held on 16.06.2021 to approve the Audited quarterly and Financial year ended results as on 31.03.2021. (As Per BSE Announcement Dated on 16/06/2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity